Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
GfV 2023
Programm
Poster
Personen
Suche
EN
Zurück
Workshop
Workshop 12
Viral vectors and gene therapy
Termin
Datum:
29.03.2023
Zeit:
13:30
–
15:00
Ort / Stream:
Lecture hall 2
Chair
Professor Christine Engeland
Witten / DE
Professor Stefan Kochanek
Ulm / DE
Programm
13:30
–
13:45
12 Min.
3 Min.
Abstract Talk
O 067
A novel recombinant HBV based selection system allows for a systematic genomic knock-out screening and the identification of host factors involved in HBV infection
Bo-Hung Liao (Munich / DE)
Viral vectors and gene therapy
13:45
–
14:00
12 Min.
3 Min.
Abstract Talk
O 068
Influenza A virus defective interfering particles as antiviral agents
Dr. Sascha Young Kupke (Magdeburg / DE)
Antiviral therapy and resistance, Viral vectors and gene therapy
14:00
–
14:15
12 Min.
3 Min.
Abstract Talk
O 069
Development of a VSV-based therapeutic HPV16 vaccine
Lydia Riepler (Innsbruck / AT)
Vaccines, Viral vectors and gene therapy
14:15
–
14:30
12 Min.
3 Min.
Abstract Talk
O 070
Harnessing mucosal immunity against respiratory viruses using adenoviral vectors expressing chemokines/cytokines as adjuvants
Ana Isabel Vieira Antao (Erlangen / DE)
Viral vectors and gene therapy
14:30
–
14:45
12 Min.
3 Min.
Abstract Talk
O 071
Molecular cloning of three cytomegaloviruses from
Mastomys natalensis
to serve as vaccine vectors against Lassa virus
Laura Staliunaite (Hamburg / DE)
Viral vectors and gene therapy
14:45
–
15:00
12 Min.
3 Min.
Abstract Talk
O 072
Long-lasting antibody delivery by a myotropic Adeno-Associated Virus (AAV) capsid variant – high serum levels, favourable glycosylation profile and protection from SARS-CoV-2 challenge
Jannik T. Wagner (Erlangen / DE)
SARS-CoV-2, Viral vectors and gene therapy
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz